Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.
Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses t…
Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...
Inquirer on MSN6h
US approves first-ever obstructive sleep apnea drug
On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
EURACTIV16h
A massive diabetes challenge and pharma-tech moonshots, Europe starts 2025 in launch mode
Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...